Primary Cells Market Worth USD 1,107.3 Million by 2023 | Leading Companies are Thermo Fisher Scientific (US),Merck KGaA (Germany), AllCells (US) and Cell Biologics (US)

primary cells market

Primary cells are cells isolated from human or animal tissues. These cells are ideal models for cancer biomarker discovery and drug screening. They are also used to understand the biochemical pathways of cellular interactions.

  • The primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 666.0 million in 2017 at a CAGR of 8.5% from 2018–2023.

Get a sample PDF copy of the Report :

Advantages of primary human cells over cell lines :

Primary human cells have a wide range of advantages over in vitro cell lines; they provide reliable tissue-specific responses in a biologically relevant microenvironment.


1. Increasing Cancer Research
2. Advantages of Primary Human Cells Over Cell Lines
3. Rapid Growth in the Biotechnology and Biopharmaceutical Industries
4. Partnerships, Collaborations, and Acquisitions Strengthening Market Growth
5. Increasing Pharmaceutical Outsourcing

Primary Cells Market, By Type :

  1. Human Primary Cells
  2. Animal Primary Cells

The base year for this study is 2017 and the forecast period is 2018–2023. The global primary cells market is segmented by origin, type, end user, and region. By origin, the primary cells market is classified into hematopoietic, skin, gastrointestinal, liver, lung, renal, heart, skeletal & muscle, and other primary cells.

The geographical regions mapped in the report are:

  • North America
  • Europe
  • Asia
  • Rest of the World

The global primary cells market is dominated by North America, followed by Europe. North America will continue to dominate the global primary cells market during the forecast period, however, Asia is expected to witness the highest CAGR, with the growth in this market centered on China and Japan.

Some key players mentioned in the research report are:

The major players in this market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics (US), PromoCell (Germany), ZenBio (US), STEMCELL Technologies (Canada), AllCells (US), American Type Culture Collection (US), and Axol Biosciences (UK).

Get a Sample Report @: